Adaptive Biotechnologies Corporation (ADPT) Earnings History
Net Loss9 years of earnings data (2017–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Adaptive Biotechnologies Corporation (ADPT) Earnings Overview
As of June 30, 2026, Adaptive Biotechnologies Corporation (ADPT) reported trailing twelve-month net income of -$50M, reflecting +63.9% year-over-year growth. The company earned $-0.32 per diluted share over the past four quarters, with a net profit margin of -21.5%.
Looking at the long-term picture, ADPT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$43M in fiscal 2017.
Adaptive Biotechnologies Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NTRA (-$226M net income, -9.0% margin), EXAS (-$208M net income, -6.4% margin), PACB (-$129M net income, -341.5% margin), ADPT has room to improve margins relative to the peer group. Compare ADPT vs NTRA →
ADPT Earnings vs Peers
Earnings metrics vs comparable public companies
ADPT Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$59M | +62.7% | -$57M | $-0.39 | -21.5% | -20.6% |
| 2024 | -$159M | +29.2% | -$163M | $-1.08 | -89.1% | -90.8% |
| 2023 | -$225M | -12.5% | -$227M | $-1.56 | -132.3% | -133.3% |
| 2022 | -$200M | +3.4% | -$200M | $-1.00 | -108.0% | -108.0% |
| 2021 | -$207M | -41.8% | -$209M | $-1.46 | -134.3% | -135.4% |
| 2020 | -$146M | -113.1% | -$153M | $-1.06 | -148.6% | -155.3% |
| 2019 | -$69M | -47.7% | -$78M | $-0.47 | -80.6% | -92.1% |
| 2018 | -$46M | -8.4% | -$50M | $-0.44 | -83.4% | -89.4% |
| 2017 | -$43M | - | -$44M | $-0.41 | -111.4% | -115.7% |
Download Data
Export ADPT earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ADPT — Frequently Asked Questions
Quick answers to the most common questions about buying ADPT stock.
What is ADPT earnings per share (EPS)?
ADPT trailing twelve-month (TTM) diluted EPS is $-0.32, reflecting +63.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2017 to 2025 is available in the table on this page.
What is Adaptive Biotechnologies Corporation's net income?
Adaptive Biotechnologies Corporation (ADPT) trailing twelve-month net income is $-50M as of 2025. Earnings grew +63.9% year-over-year.
Is ADPT profitable?
ADPT is not currently profitable on a TTM basis, reporting a net loss of $-50M. Net margin is -21.5%. Investors should monitor for a return to profitability.
What is ADPT's earnings growth rate?
ADPT compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2017 to 2025.
What are ADPT's profit margins?
Adaptive Biotechnologies Corporation net profit margin is -21.5%, operating margin is -20.6%, and gross margin is +74.2%. Below-average margins reflect competitive or cost pressures. Return on Equity is -27.8%.
Is ADPT growing earnings?
Yes, ADPT earnings are accelerating — EPS growth of +63.9% exceeds the 5-year CAGR of N/A. TTM net income reached $-50M. Earnings momentum is strengthening.
What was ADPT's best earnings year?
Adaptive Biotechnologies Corporation's highest annual net income on record is $-43M, achieved in fiscal year 2017. Earnings history on this page spans 2017 to 2025 and includes all annual and quarterly figures.
What were ADPT's earnings last quarter?
ADPT's most recent reported quarter was Q1 2026. Net income was $-20M with diluted EPS of $-0.13. For a full breakdown of all quarters, see the quarterly earnings table on this page.